1-6 of 6
Katherine Parker Ponder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An ounce of prevention potentiates a pound of cure for hemophilia A

Katherine Parker Ponder
Journal: Blood
Blood (2005) 105 (7): 2620.
https://doi.org/10.1182/blood-2005-01-0245
Published: 2005
Journal Articles

A more clinically relevant mouse model of hemophilia B

Katherine Parker Ponder
Journal: Blood
Blood (2004) 104 (6): 1595.
https://doi.org/10.1182/blood-2004-06-2397
Published: 2004
Journal Articles

Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs

Jun Zhang, Lingfei Xu, Mark E. Haskins, Katherine Parker Ponder
Journal: Blood
Blood (2004) 103 (1): 143–151.
https://doi.org/10.1182/blood-2003-06-2181
Published: 2004
Journal Articles

Novel therapies for hemophilia A

Katherine Parker Ponder
Journal: Blood
Blood (2003) 102 (12): 3857–3858.
https://doi.org/10.1182/blood-2003-09-3208
Published: 2003
Journal Articles

Neonatal or hepatocyte growth factor–potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B

Lingfei Xu, Cuihua Gao, Mark S. Sands, Shi-Rong Cai, Timothy C. Nichols, Dwight A. Bellinger, Robin A. Raymer, Stephanie McCorquodale, Katherine Parker Ponder
Journal: Blood
Blood (2003) 101 (10): 3924–3932.
https://doi.org/10.1182/blood-2002-10-3050
Published: 2003
Journal Articles

Therapeutic Levels of Functional Human Factor X in Rats After Retroviral-Mediated Hepatic Gene Therapy

MaiThao Le, Torayuki Okuyama, Shi-Rong Cai, Susan C. Kennedy, William M. Bowling, M. Wayne Flye, Katherine Parker Ponder
Journal: Blood
Blood (1997) 89 (4): 1254–1259.
https://doi.org/10.1182/blood.V89.4.1254
Published: 1997